Thyroid-stimulating hormone, leptin and insulin resistance in patients with obesity after bariatric surgery

BACKGROUND: The function of the thyroid gland effects on obesity and comorbidities. It has been proven for bariatric surgery to be the most effective in obesity treatment.

AIM: to evaluate the dynamics of body weight, thyroid status, leptin and insulin resistance in obese patients after bariatric surgery.

MATERIALS AND METHODS: 74 obese patients were observed after bariatric surgery (sleeve gastrectomy – 42, gastric bypass - 32); initial body mass index (BMI), thyroid stimulating hormone, free T4, fasting plasma leptin, insulin and glucose were estimated; the insulin resistance index HOMA-IR was calculated. The dynamics of body weight was estimated by BMI and the excess BMI loss (% EBMIL). After 3 years of follow-up, 48 patients were examined.

RESULTS: Subclinical hypothyroidism (SH) was detected in 36.5% of patients with high degrees of obesity. A correlation was found between BMI and TSH level (R=0.5; p=0.01). HOMA-IR was increased in most patients with obesity of the II and III degree (4.8±1.9 ng / ml). In the SH group, the leptin level was significantly higher than in the group with a normal TSH level of 43.0±7.3 ng / ml and 33.2±4.6 ng / ml (p=0.004). Among patients with initial SH, spontaneous reduction of TSH levels occurred in 45% patients 3 years after surgery.

CONCLUSIONS: Postoperatively, the BMI decrease was associated with the decrease of TSH, leptin and HOMA-IR. The data obtained may reflect the effect of adipose tissue on the functional state of the thyroid gland in patients with high degrees of obesity after bariatric surgery. This seems to be extremely important for maintaining body weight.

obesity, thyroid stimulating hormone, leptin, insulin resistance, bariatric surgery

1. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822-1832. DOI:10.1007/s11695-015-1657-z

2. Захарова С.М., Савельева Л.В., Фадеева М.И. Ожирение и гипотиреоз // Ожирение и метаболизм. – 2013. – Т. 10. – № 2. – С. 54–58. [Zakharova SM, Savelieva LV, Fadeeva MI. Obesity and hypothyroidism. Obesity and metabolism. 2013;10(2):54-58. (In Russ.)] DOI:10.14341/2071-8713-4826

3. Oh JY, Sung YA, Lee HJ. Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women. Korean J Intern Med. 2013;28(2):180-186. DOI:10.3904/kjim.2013.28.2.180

4. Ren R, Ma Y, Deng F, et al. Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study. Diabetes Metab Syndr Obes. 2019;12:1563-1569. DOI:10.2147/DMSO.S202769

5. Oge A, Bayraktar F, Saygili F, et al. TSH influences serum leptin levels independent of thyroid hormones in hypothyroid and hyperthyroid patients. Endocr J. 2005;52(2):213-217. DOI:10.1507/endocrj.52.213

6. Higa K, Ho T, Tercero F, et al. Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7(4):516-525. https://doi.org/10.1016/j.soard.2010.10.019.

7. Brethauer SA, Kim J, El Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25(4):587-606. DOI:10.1007/s11695-015-1645-3

8. Sheehan MT. Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care. Clin Med Res. 2016;14(2):83-92. DOI:10.3121/cmr.2016.1309

9. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-382. DOI:10.1152/physrev.00030.2013

10. Романцова Т.И., Островская Е.В. Метаболически здоровое ожирение: дефиниции, протективные факторы, клиническая значимость // Альманах клинической медицины. – 2015;1(1):75-86. [Romantsova TI, Ostrovskaya EV. Metabolically healthy obesity: definitions, protective factors, clinical relevance. Almanac of clinical medicine. 2015;1(1):75-86. (In Russ.)] DOI:10.18786/2072-0505-2015-1-75-86

11. Roberson LL, Aneni EC, Maziak W. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review. BMC Public Health. 2014;14:14. DOI:10.1186/1471-2458-14-14